JudyCBougheyMDFACS

Breast

Professor of Surgery, Mayo Medical School W. H. Odell Professor of Individualized Medicine, Chair, Division of Breast and Melanoma Surgical Oncology, Program Director - Breast Surgery Fellowship

Join to view full profile

Dr. Boughey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Boughey's full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511

Summary

Dr. Judy Boughey is a Breast Surgical Oncologist in Rochester, MN. She received her medical degree from the University of Cambridge, completed her residency in General Surgery at University of South Carolina, and completed a fellowship in Breast Surgical Oncology at the University of Texas M D Anderson Cancer Center. Dr. Boughey's experience lies in breast cancer and benign breast disease, and procedures such as breast conserving surgery, nipple sparing mastectomy, sentinel lymph node surgery and axillary lymph node dissection. She has published research on topics related to breast cancer in multiple journals and has been the principal investigator of several clinical trial. She is a fellow of the American College of Surgeons.

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2005 - 2006
Prisma Health/University of South Carolina SOM Columbia (Columbia)Residency, Surgery, 1999 - 2005
School of Clinical Medicine, University of CambridgeClass of 1997

Certifications & Licensure

MN State Medical License 2006 - 2025
TX State Medical License 2005 - 2007
SC State Medical License 2002 - 2005
American Board of Surgery Surgery

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Fellow American College of Surgeons

Clinical Trials

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer Start of enrollment: 2009 Jul 01
Completed
Phase 2
Detection of Aggressive Breast Tumors Using Tc-99m-NC100692 Start of enrollment: 2008 May 01
Completed
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
Recruiting
Phase 2
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer Start of enrollment: 2012 Jul 01
Completed
Phase 2
Breast Cancer Genome Guided Therapy Study (BEAUTY) Start of enrollment: 2013 Feb 01
Active, not recruiting
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer Start of enrollment: 2020 Jan 10
Recruiting
Phase 2
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer Start of enrollment: 2021 Jan 13
Recruiting
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy Start of enrollment: 2014 Feb 07
Active, not recruiting
Phase 3
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy Start of enrollment: 2017 Jan 20
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

American College of Surgeons Cancer Program Annual Report from 2021 Participant User File.
Elizabeth B Habermann, Courtney N Day, Bryan E Palis, Jennifer K Plichta, Nabil Wasif
Journal of the American College of Surgeons. 2025-01-01
Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer.
Hope S Rugo, Mike Campbell, Christina Yau, A Jo Chien, Anne M Wallace
Breast Cancer Research and Treatment. 2024-12-03
In-Breast Tumor Progression During Neoadjuvant Chemotherapy: Impact on and Factors Influencing Distant Recurrence-Free Survival.
Kathryn M Eckert, Tanya L Hoskin, Carrie A Olson, Matthew P Goetz, Judy C Boughey
Annals of Surgical Oncology. 2024-12-01

Journal Articles

Association of Low Nodal Positivity Rate Among Patients with ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Che...
Henry M Kuerer, Judy C Boughey, Alison U Barron, E Shelley Hwang, JAMA
The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial
Kelly K Hunt, Armando Giuliano, Judy C Boughey, Laurie Cuttino, Kari M Rosenkranz, Bruce Haffty, Annals of Surgical Oncology
Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
James W Jakub, Amy C Degnim, Tina J Hieken, Judy C Boughey, Annals of Surgical Oncology
Predicting Non-Sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy
Judy C Boughey, Alison U Barron, Annals of Surgical Oncology
Treatment Outcomes for Pleomorphic Lobular Carcinoma in Situ of the Breast
Judy C Boughey, Tina J Hieken, Annals of Surgical Oncology
Join now to see all

Lectures

Effect of Primary Breast Tumor Location on Axillary Nodal Positivity
Mayo School of Continuous Professional Development, Rochester, Minnesota - 11/7/2012
ASCO 2018: Dr. Judy C. Boughey on Neoadjuvant Chemotherapy for Breast Cancer Patients
Rochester, MN - 10/28/2014
Factors associated with lymphedema in patients/women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection on a prospective cl...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Authored Content

ASCO 2018: Dr. Judy C. Boughey on Neoadjuvant Chemotherapy for Breast Cancer PatientsJune 2018

Press Mentions

More Cancers Are Being Treated with Personalised Therapies Before SurgeryDecember 4th, 2024
Breast Cancer Surgery: Understanding Your OptionsOctober 15th, 2024
Top 10 Takeaways to Implement into Practice Following ASBrSMay 8th, 2023
Join now to see all